Atopic Dermatitis Therapeutics

Signum Dermalogix Grant Totaling $1.6m for The Development of a Topical Drug Candidate
Nov 18, 2013
Signum Dermalogix, a biopharmaceutical company, has announced that the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded the company a Small Business Innovation Research (SBIR) Phase II grant totaling ...

Tags: Atopic Dermatitis Therapeutics, Medicine